Parameswaran Hari
Hematology & Oncology · Milwaukee, WINPI 1083665814
Payments from drug & device makers
Across 489 payments — averaging $11,759 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$1.4M
- Janssen Research & Development, LLC$857K
- Sanofi$821K
- Pfizer$796K
- Amgen$666K
- Takeda Pharmaceuticals U.S.A., Inc.$383K
- plus $805K from 23 others
Across 68 payments — averaging $7584.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$281K
- Takeda Pharmaceuticals U.S.A., Inc.$174K
- Janssen Research & Development, LLC$59K
- Sanofi$1K
- Regeneron$335
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 91 | $1,421,644 |
| Janssen Research & Development, LLC | 52 | $857,467 |
| Sanofi | 19 | $820,541 |
| Pfizer | 46 | $796,238 |
| Amgen | 43 | $666,230 |
| Takeda Pharmaceuticals U.S.A., Inc. | 54 | $382,783 |
| GSK | 27 | $250,163 |
| Novartis | 3 | $135,396 |
| Karyopharm Therapeutics Inc. | 36 | $134,933 |
| Regeneron | 9 | $77,986 |
| Shire North American Group Inc | 12 | $56,401 |
| E.r. Squibb & Sons, L.L.C. | 6 | $35,884 |
| Johnson & Johnson | 26 | $26,753 |
| Sanofi-aventis U.S. LLC | 4 | $19,925 |
| Incyte Corporation | 15 | $17,776 |
| Celularity Inc. | 4 | $12,649 |
| Adaptive Biotechnologies Corporation | 13 | $10,901 |
| Sanofi US Services Inc. | 8 | $7,031 |
| Kadmon Pharmaceuticals LLC | 4 | $6,118 |
| Janssen Global Services, LLC | 3 | $4,535 |
| Merck | 3 | $2,572 |
| Omeros Corporation | 1 | $2,250 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $2,100 |
| Genentech, Inc. | 3 | $1,282 |
| Kadmon Corporation LLC | 1 | $144 |
| Genmab U.S., Inc. | 1 | $111 |
| Jazz Pharmaceuticals Inc. | 1 | $106 |
| Rigel Pharmaceuticals, Inc. | 1 | $60 |
| TG Therapeutics, Inc. | 1 | $56 |
How this compares
$5,750,034 in reported general payments places this provider in the 95th percentile of 248 hematology & oncology providers in Wisconsin.
Other hematology & oncology in Milwaukee
- Binod DhakalMilwaukee$13.9M
- Ehab AtallahMilwaukee$13.3M
- Guru Subramanian Guru MurthyMilwaukee$7.2M
- Meera MohanMilwaukee$5.6M
- Deepak KilariMilwaukee$4.7M
- Kathryn BylowMilwaukee$4.5M
- Sayed Mehdi HamadaniMilwaukee$3.7M
- Anita DsouzaMilwaukee$3.7M
- Sameem AbedinMilwaukee$3.3M
- Wael SaberMilwaukee$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.